NCT01935570View on ClinicalTrials.gov

Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy Volunteers

Interventions

DRUG

Magnesium chloride (ChronoMag Smart Tablet®)

DRUG

Magnesium carbonate (Mag2® Tablet)

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors

collaborator

Dr Gisèle PICKERING (MCU-PH)(Clinical Pharmacology center, Inserm 501)

UNKNOWN

collaborator

Dr Gilles DUCHEIX (Attaché)(Clinical Pharmacology center, Inserm 501)

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT01935570 - Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg. | Biotech Hunter | Biotech Hunter